Modeling potential outcomes of a change in nomenclature

Closed Pre-Solicitation Posted

Solicitation number
75D-301-22-R-72219
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Atlanta, Georgia 30341, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Centers for Disease Control and Prevention intends to award a justification for other than full and open contract to Fred Hutch Cancer Center to conduct comparative modeling of potential outcomes if Gleason score 6 prostate cancer were reclassified as a non-cancer diagnosis. Fred Hutch Cancer Center would perform the modeling through its CISNET prostate cancer working group and produce a report summarizing the results and suggested clinical protocols. Interested parties may identify their capabilities by April 18, 2022, after which the CDC will determine whether to pursue a competitive procurement.

There is no set-aside designation for this opportunity. Fred Hutch Cancer Center is identified as housing the CISNET prostate cancer working group that would perform the work. The anticipated period of performance is from September 1, 2022 through August 31, 2023. The contract value was not specified but would likely be commensurate with the modeling and analysis required to be conducted by the CISNET group over the one year period of performance.

Notice text

The Centers for Disease Control and Prevention intends to award a Justification For Other Than Full and Open contract to Fred Hutch Cancer Center.

We propose to contract with Fred Hutch Cancer Center, which houses the CISNET prostate group consortium, to model possible downstream implications of changing nomenclature of GS6 prostate cancer. These findings will be used to inform policy decisions on appropriate nomenclature for GS6 tumors.

There are many potential implications to a change in nomenclature, particularly for a highly prevalent cancer such as prostate.  We propose a series of models to be conducted by the CISNET prostate cancer working group, housed at Fred Hutch Cancer Center, to explore impacts of a change in nomenclature on clinical treatment profiles to include the number of follow up biopsies, number of men requiring treatment, metastases, and prostate cancer deaths that may occur as a function of the change. Models may include other biomarkers or imaging tests that are often included in clinical active surveillance protocols.

The target audience for dissemination of results consists of medical providers who advise, consult, and treat newly diagnosed prostate cancer patients as well as those that may be involved in their medical and psychological care and payment of treatment and other services. This audience may consist of pathologists, urologists, radiation oncologists, medical oncologists, molecular biologists, bioethicists, psychometricians, economists, health services researchers, cancer registrars and reporters, and patient advocates. 

Report Summarizing CISNET findings

CISNET investigators, together with CDC collaborators, will produce a report on this project summarizing the comparative modeling of the outcomes of reclassifying GS6 cancers as non-cancers along with suggested clinical protocols for managing the reclassified GS6 patient. We expect no ramifications for cancer registry operations that will still capture GS6 tumors as GS6.

This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of 6.302-1 and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government.  A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government.  Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.  Any quotation/response should be emailed to contract specialist at vwa8@cdc.gov by COB 18,  April, 2022.

Files

File Type Posted
Statement of Work.docx DOCX document

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors